Search Results - "Glimelius, B"

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Glimelius, B, Tiret, E, Cervantes, A, Arnold, D

Get full text

TOSCA—a delicious Swedish almond cake, an Italian opera and an Italian trial with important new data by Glimelius, B.

Get full text

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013 by Papamichael, D., Audisio, R.A., Glimelius, B., de Gramont, A., Glynne-Jones, R., Haller, D., Köhne, C.-H., Rostoft, S., Lemmens, V., Mitry, E., Rutten, H., Sargent, D., Sastre, J., Seymour, M., Starling, N., Van Cutsem, E., Aapro, M.

“…Clinicians managing colorectal cancer patients need to appreciate that more than 60% of their patients are >70 years of age, and that these proportions may…”
Get full text

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy by Hamfjord, J., Guren, T.K., Dajani, O., Johansen, J.S., Glimelius, B., Sorbye, H., Pfeiffer, P., Lingjærde, O.C., Tveit, K.M., Kure, E.H., Pallisgaard, N., Spindler, K.-L.G.

“…Metastatic colorectal cancer (mCRC) is a heterogeneous disease where prognosis is dependent both on tumor biology and host factors. Total circulating cell-free…”
Get full text

Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin by Bujko, K, Glimelius, B, Valentini, V, Michalski, W, Spalek, M

“…Abstract Background There is no consensus on the role of postoperative chemotherapy in patients with rectal cancer who have received preoperative…”
Get full text

Tumour regression in the randomized Stockholm III Trial ofradiotherapy regimens for rectal cancer by Pettersson, D., Loerinc, E., Holm, T., Iversen, H., Cedermark, B., Glimelius, Bengt, Martling, A.

“…BackgroundThe Stockholm III Trial randomized patients with primary operable rectal cancers to either short-course radiotherapy (RT) with immediate surgery…”
Get full text

Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer by Pettersson, D., Lörinc, E., Holm, T., Iversen, H., Cedermark, B., Glimelius, B., Martling, A.

“…Background The Stockholm III Trial randomized patients with primary operable rectal cancers to either short‐course radiotherapy (RT) with immediate surgery…”
Get full text

Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer by Pettersson, D., Cedermark, B., Holm, T., Radu, C., Påhlman, L., Glimelius, B., Martling, A.

“…Background: To address issues regarding the fractionation of radiotherapy (RT) and timing of surgery for rectal cancer, a multicentre trial has randomized…”
Get full text

Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer by Pettersson, D., Holm, T., Iversen, H., Blomqvist, L., Glimelius, B., Martling, A.

“…Background: Short‐course radiotherapy (SRT) with immediate surgery and long‐course chemoradiotherapy (CRT) are currently the standard preoperative treatment…”
Get full text

Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology by Glimelius, B., Lahn, M.

“…The introduction of molecular targeted agents (e.g. monoclonal antibodies or kinase inhibitors) and cancer vaccines has raised the question whether alternate…”
Get full text

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making by Schmoll, H.J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C.J., Balmana, J., Regula, J., Nagtegaal, I.D., Beets-Tan, R.G., Arnold, D., Ciardiello, F., Hoff, P., Kerr, D., Köhne, C.H., Labianca, R., Price, T., Scheithauer, W., Sobrero, A., Tabernero, J., Aderka, D., Barroso, S., Bodoky, G., Douillard, J.Y., El Ghazaly, H., Gallardo, J., Garin, A., Glynne-Jones, R., Jordan, K., Meshcheryakov, A., Papamichail, D., Pfeiffer, P., Souglakos, I., Turhal, S., Cervantes, A.

“…Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation…”
Get full text

Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial by Cashin, P.H, Mahteme, H, Spång, N, Syk, I, Frödin, J.E, Torkzad, M, Glimelius, B, Graf, W

“…Abstract Background First-line treatment of isolated resectable colorectal peritoneal metastases remains unclear. This study (the Swedish peritoneal study)…”
Get full text

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial by Breugom, A.J., van Gijn, W., Muller, E.W., Berglund, Å., van den Broek, C.B.M., Fokstuen, T., Gelderblom, H., Kapiteijn, E., Leer, J.W.H., Marijnen, C.A.M., Martijn, H., Meershoek-Klein Kranenbarg, E., Nagtegaal, I.D., Påhlman, L., Punt, C.J.A., Putter, H., Roodvoets, A.G.H., Rutten, H.J.T., Steup, W.H., Glimelius, B., van de Velde, C.J.H.

“…The results of the PROCTOR-SCRIPT trial could not demonstrate a significant benefit of adjuvant chemotherapy with fluoropyrimidine monotherapy regarding…”
Get full text

Population-based data from the Swedish Colon Cancer Registry by Kodeda, K., Nathanaelsson, L., Jung, B., Olsson, H., Jestin, P., Sjövall, A., Glimelius, B., Påhlman, L., Syk, I.

“…Background Evaluating the external validity of clinical trials requires knowledge not only of the study population but also of a relevant reference population…”
Get full text

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic by Marijnen, C.A.M., Peters, F.P., Rödel, C., Bujko, K., Haustermans, K., Fokas, E., Glynne-Jones, R., Valentini, V., Spindler, K-L.G., Guren, M.G., Maingon, Philippe, Calvo, F.A., Pares, O., Glimelius, B., Sebag-Montefiore, D.

Get full text

Emerging risk factors of recurrence and overall survival in a Swedish stage I-III colon cancer cohort by Osterman, E., Mezheyeuski, A., Sjöblom, T., Glimelius, B.

Get full text

What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait? by Glimelius, B, Martling, A

Get more information

Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy by Erlandsson, J., Pettersson, D., Glimelius, B., Holm, T., Martling, A.

“…Background The optimal timing of surgery for rectal cancer after radiotherapy (RT) is disputed. The Stockholm III trial concluded that it was oncologically…”
Get full text

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel by Nordlinger, B., Van Cutsem, E., Gruenberger, T., Glimelius, B., Poston, G., Rougier, P., Sobrero, A., Ychou, M.

“…The past 5 years have seen the clear recognition that the administration of chemotherapy to patients with initially unresectable colorectal liver metastases…”
Get full text

Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer by Sorbye, H., Cvancarova, M., Qvortrup, C., Pfeiffer, P., Glimelius, B.

“…In metastatic colorectal cancer (mCRC) trials, median survival has increased from 6 months to above 20 months during the previous decades. Uncertainty exists…”
Get full text